News Parabilis prices IPO at an ambitious $475 million Parabilis has set the terms of its IPO, seeking to raise a hefty $475m for phase 3 trials of its lead drug for desmoid tumours.
News NewLimit raises $435m for liver trials, and other financings Longevity biotech NewLimit's $435m Series C heads this week's round-up of biotech venture capital financings.
News GHO, CBC merge to create largest healthcare investment firm Two top healthcare investors – UK-based GHO and CBC Group of Singapore – have announced a merger to create a massive player in the category.
News Isomorphic raises $1.2bn for AI drug hunt Isomorphic Labs has added to the lustre attached to its AI-powered drug discovery engine by raising an eye-watering $1.2 billion in a Series B round.
News Windward raises $165m for TSLP drug, and other biofinancings Recent biotech financings include nine-figure rounds for Windward Bio and Coultreon, with Vivacta, Kanvas, and Moleculent also raising funds.
News CellCentric pockets $220m for blood cancer programme CellCentric has raised $220 million in a Series D financing that will help fund pivotal trials of p300/CBP inhibitor inobrodib in multiple myeloma.
News Roche develops Bundibugyo Ebola test in six days A PCR diagnostic developed by Roche for the Bundibugyo form of Ebola is being offered to health systems at the front lines of the current outbreak.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
